Novonesis

New name for Novozymes and Hansen merger

The merger of the biologicals businesses Novozymes and Chr. Hansen will trade as Novonesis, once all regulatory approvals are in place. The proposal to merge the two businesses into a single €3.5 billion company was made in December 2022 by Novo Holdings – the largest...

read more
.